INTERNAL SHUNT AND METHOD FOR TREATING GLAUCOMA

• US 20100152641A1
• Filed: 02/23/2010
• Published: 06/17/2010
• Est. Priority Date: 05/05/2003
• Status: Active Grant

• Current Assignee: Alcon Incorporated
• Original Assignee: Transcend Medical Incorporated (Alcon Incorporated)
• Inventors: Yablonski, Michael
• Granted Patent: US 8,444,588 B2
• Time in Patent Office: Days
• US Class Current: 604/8
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002
• CPC Class Codes: A61M 1/36 Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
• CPC Class Codes: A61M 27/00 Drainage appliance for wounds or the like , i.e. wound drains, implanted drains negative pressure wound therapy devices A61M1/90; implements for holding wound open A61B17/02 ; middle ear drainage A61F11/202

Abstract

A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.

Claims

1. A method of treating glaucoma, comprising:

providing an elongated tube comprising at least one inflow port, at least one outflow port and an internal fluid passageway communicating between the at least one inflow port and at least one outflow port; and

implanting the tube entirely within an interior of the eye such that the at least one inflow port of the fluid passageway is positioned in and communicates with the anterior chamber and the at least one outflow port of the fluid passageway communicates with the suprachoroidal space; and

diverting aqueous humor through the fluid passageway from the anterior chamber to the suprachoroidal space.

2. A method as in claim 1, wherein implanting the tube entirely within an interior of the eye comprises implanting the tube so that the tube is positioned radially inward of an outer surface of the sclera.

3. A method as in claim 1, wherein implanting the tube entirely within an interior of the eye comprises implanting the tube so that at least one inflow port is positioned in the anterior chamber posterior of an inner surface of the cornea.

4. A method as in claim 1, further comprising using a driving force of protein colloidal osmotic pressure in the eye to maximize flow of the aqueous humor through the fluid passageway to reduce intraocular pressure.

5. The method of claim 1,wherein diverting aqueous humor comprises flowing aqueous humor through the fluid passageway without transcleral egress of aqueous humor from the eye.

6. The method of claim 1, wherein implanting the tube comprises leaving no transcleral route in the eye.

7. The method of claim 1, wherein the tube comprises a rounded, outer surface that contacts a portion of the sclera.

8. The method of claim 4, further comprising attaching a retaining structure to an end of the tube.

9. The method of claim 8, wherein the retaining structure comprises a suture attached to a distal end of the shunt.

10. The method of claim 1, further comprising cutting the tube prior to implantation.

11. A method of treating glaucoma, comprising:

providing a tube having an internal lumen, a first opening for fluid to flow into the internal lumen, and a second opening for fluid to flow out of the internal lumen;

positioning the tube inside an eye so that the first opening is inside the anterior chamber and the second opening communicates with the suprachoroidal space; and

causing fluid to flow from the anterior chamber into the internal lumen through the first opening and out of the internal lumen into the suprachoroidal space through the second opening.

12. A method as in claim 11, wherein positioning the tube inside an eye comprises implanting the tube so that the tube is positioned radially inward of an outer surface of the sclera.

13. A method as in claim 11, wherein implanting the tube inside an eye comprises implanting the tube so that the first opening is positioned in the anterior chamber posterior of an inner surface of the cornea.

15. The method of claim 11, further comprising leaving no transcleral route in the eye.

16. A method as in claim 11, further comprising using a driving force of protein colloidal osmotic pressure in the eye to maximize flow of the aqueous humor through the internal lumen to reduce intraocular pressure.

17. The method of claim 11, wherein the tube comprises a rounded, outer surface that contacts a portion of the sclera.